SHL Medical returns to PFSS Tokyo 2024

SHL Medical is excited to announce our participation in the 2024 Prefilled Syringe Seminar (PFSS) on September 10-11 in Tokyo, Japan. Organized by the Parenteral Drug Association (PDA) Japan Chapter, this year’s event will bring together industry leaders in the self-injection space.

Visit our tabletop for a personal demo of our market-proven Molly^® autoinjector. Discover how its modular technology enables SHL to support the launch of various innovative combination products across multiple disease areas, including cardiometabolic diseases. This year, SHL Medical’s Eric Linvill, PhD will present our research on autoinjector activation on human soft tissue. Understanding injection performance across different body compositions is key to enhancing patient experience, especially in cardiometabolic care. Don’t miss his presentation on September 10 at 10:50 AM JST!

Last year, SHL expanded Molly’s technology to include the option of integrating digital connectivity with the Molly Connected Cap. The Connected Cap is a retrofittable add-on technology that collects and transmits injection data to support the enhancement of patient monitoring and adherence. Learn more about Molly’s evolution directly from our representatives.

With the global demand for autoinjectors on the rise, it is more crucial than ever for cutting-edge device technology to be accompanied by advanced manufacturing capabilities. SHL has been expanding our facilities worldwide and strengthening our integrated capabilities through various acquisitions and partnerships. Talk to our representatives to discover how our global manufacturing presence can support pharma and biotech companies in delivering the combination products of the future.

Register today and join us in Tokyo for another insightful experience!

Meet our speaker!

Where   : Sola City Conference Center, Tokyo, Japan | Tabletop #13

When    : September 10-11